Results 31 to 40 of about 30,955 (215)

The chronic care for age-related macular degeneration study (CHARMED): Study protocol for a randomized controlled trial

Trials, 2011
Background Neovascular age-related macular degeneration is the leading cause of irreversible blindness in people 50 years of age or older in the developed world.
Held Ulrike, Wang Mathyas, Woitzek Katja, Frei Anja, Rosemann Thomas   +4 more
doaj   +1 more source

Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration [PDF]

, 2016
Purpose To define a minimum set of outcome measures for tracking, comparing, and improving macular degeneration care. Design Recommendations from a working group of international experts in macular degeneration outcomes registry development and patient ...
Barthelmes, D. (Daniel), Blumenkranz, M. (Mark), Cheung, G. (Gemmy), Gillies, M.C. (Mark), Haller, J. (Julia), Johnston, R. (Robert), Kim, R. (Ramasamy), Klaver, C.C.W. (Caroline), McKibbin, M. (Martin), Ngah, N.F. (Nor Fariza), Pershing, S. (Suzann), Rodrigues, I.A. (Ian A.), Shankar, D. (Dato), Sprinkhuizen, S.M. (Sara M.), Tamura, H. (Hiroshi), Tufail, A. (Adnan), Weng, C.Y. (Christina Y.), Westborg, I. (Inger), Yelf, C. (Catherine), Yoshimura, N.   +19 more
core   +4 more sources

Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing [PDF]

, 2011
Background/aims: With the increased efficacy of current therapy for wet age-related macular degeneration (AMD), better ways to detect wet AMD are needed.
Bababeygy, Simon R., Fink, Wolfgang, Jivrajka, Renu V., Robison, Craig D., Sadun, Alfredo A., Sebag, J.   +5 more
core   +1 more source

Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules [PDF]

, 2019
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD), such as neuroprotective drugs, and complement inhibitors, also called ...
Cerini, Alberto, Greco A., La Cava M, Lambiase A, Limoli PG, Nebbioso M   +5 more
core   +1 more source

Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol. [PDF]

, 2020
AimTo show the characteristics and outcomes of patients with neovascular age-related macular degeneration (nAMD) who had extended remission (ER) while on a pro re nata (PRN) treatment protocol.MethodsThis was a retrospective case-control study of a ...
Amador-Patarroyo, Manuel J, Cheng, Lingyun, Dans, Kunny C, Freeman, William R, Lin, Tiezhu, Meshi, Amit, Muftuoglu, Ilkay Kilic   +6 more
core  

Vascular Response to Sildenafil Citrate in Aging and Age-Related Macular Degeneration. [PDF]

, 2019
Age-related macular degeneration (AMD) - the leading cause of vision loss in the elderly - share many risks factors as atherosclerosis, which exhibits loss of vascular compliance resulting from aging and oxidative stress.
Agrawal, Rupesh, Cheung, Chui Ming Gemmy, Cunefare, David, Farsiu, Sina, Khandelwal, Neha, Migacz, Justin, Tran, Steven, Vuong, Vivian S, Yiu, Glenn   +8 more
core   +2 more sources

Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation

EBioMedicine, 2018
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly in developed countries. Neovascular AMD (nAMD) accounts for 90% of AMD-related vision loss.
Karis Little, Jacey H. Ma, Nan Yang, Mei Chen, Heping Xu   +4 more
doaj   +1 more source

Unusual visual loss in a patient with exudative macular degeneration

American Journal of Ophthalmology Case Reports, 2022
Purpose: To describe a case of marked vision loss in a patient with neovascular age-related macular degeneration after choroidal neovascular membrane (CNV) improvement and stabilization.
Enoch T. Peng, Sean D. Adrean
doaj   +1 more source

Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. [PDF]

, 2013
BACKGROUND: Diseases of the posterior segment of the eye, including age-related macular degeneration (AMD), have recently been recognised as the leading or second leading cause of blindness in several African countries.
Bastawrous, Andrew, Foster, Allen, Kuper, Hannah, Leung, Irene, Mathenge, Wanjiku, Peto, Tunde   +5 more
core   +6 more sources

Dietary fatty acids and lipoproteins on progression of age-related macular degeneration [PDF]

, 2017
Age-related macular degeneration (AMD) is a medical condition of central loss vision and blindness. Numerous studies have revealed that changes on certain dietary fatty acids (FAs) could have useful for AMD management.
Abia González, María del Rocío, Bermúdez Pulgarín, Beatriz, García Muriana, Francisco José, López Martín, Sergio, Montserrat de la Paz, Sergio, Naranjo Gutiérrez, María del Carmen   +5 more
core   +3 more sources